Purpose-Built Platform for Human Metalloenzyme-Targeted Medicines
Employees: 11-50
Total raised: $3.3M
Founded date: 2021
Investors 1
| Date | Name | Website |
| - | MP Healthc... | mp-healthc... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 21.02.2024 | - | $3.3M | - |
Mentions in press and media 6
| Date | Title | Description |
| 03.07.2025 | Blacksmith Medicines Granted U.S. Patent Covering Antibacterial Compounds Targeting LpxC | - |
| 21.02.2024 | Blacksmith Medicines Gets $3.3M Via NIH Funding | San Diego-based Blacksmith Medicines, a developer of biopharmaceuticals, says it has received $3.3M in funding from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH). Accordin... |
| 12.01.2021 | Blacksmith Medicines Raises Seed Funding | Blacksmith Medicines, a San Diego, CA-based biotechnology company focused on creating novel medicines for immuno-oncology and inflammatory diseases by targeting human metalloenzymes, raised a seed funding of undisclosed amount. The company ... |
| 09.01.2021 | Startup Funding News for the Day – Medtech Sector | These are a few US-based startups that raised funding today: |
| 08.01.2021 | Blacksmith Medicines Launches With Seed Funding and a Research Collaboration With Lilly | |
| 08.01.2021 | Blacksmith Medicines Gets Seed Funding | San Diego-based Blacksmith Medicines, a new biotechnology company focused on creating medicines for immuno-oncology and inflammatory diseases by targeting human metalloenzymes, has raised a round of seed funding, and announced a research de... |